POTENZA, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.325
EU - Europa 8.531
AS - Asia 5.256
SA - Sud America 472
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 10
Totale 33.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.192
GB - Regno Unito 2.781
IT - Italia 1.783
HK - Hong Kong 1.629
SG - Singapore 1.455
CN - Cina 1.322
SE - Svezia 1.108
DE - Germania 763
RU - Federazione Russa 543
BR - Brasile 418
FI - Finlandia 367
UA - Ucraina 350
TR - Turchia 248
FR - Francia 225
ID - Indonesia 167
BG - Bulgaria 163
IN - India 99
KR - Corea 97
CA - Canada 88
VN - Vietnam 68
NL - Olanda 67
BE - Belgio 64
CZ - Repubblica Ceca 62
IE - Irlanda 55
AT - Austria 38
LT - Lituania 30
IR - Iran 26
JP - Giappone 24
BZ - Belize 22
ES - Italia 18
EU - Europa 18
MY - Malesia 18
PL - Polonia 15
AR - Argentina 13
RO - Romania 13
BD - Bangladesh 12
MX - Messico 12
CH - Svizzera 11
DK - Danimarca 11
PH - Filippine 11
AU - Australia 10
CO - Colombia 9
EC - Ecuador 9
SI - Slovenia 9
SK - Slovacchia (Repubblica Slovacca) 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
IQ - Iraq 7
MA - Marocco 7
PK - Pakistan 7
PT - Portogallo 7
AZ - Azerbaigian 6
GR - Grecia 6
NO - Norvegia 6
UZ - Uzbekistan 6
KG - Kirghizistan 5
LU - Lussemburgo 5
NG - Nigeria 5
PA - Panama 5
SA - Arabia Saudita 5
AL - Albania 4
DZ - Algeria 4
IL - Israele 4
MK - Macedonia 4
NP - Nepal 4
OM - Oman 4
PE - Perù 4
RS - Serbia 4
TW - Taiwan 4
VE - Venezuela 4
ZA - Sudafrica 4
BH - Bahrain 3
EG - Egitto 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BN - Brunei Darussalam 2
EE - Estonia 2
IM - Isola di Man 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
PY - Paraguay 2
TH - Thailandia 2
A1 - Anonimo 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
Totale 33.637
Salva come PNG Salva come JPEG
Città #
Fairfield 2.629
Santa Clara 2.144
Southend 1.888
Hong Kong 1.622
Woodbridge 1.514
Ashburn 1.461
Chandler 1.328
Houston 1.250
Seattle 1.016
Ann Arbor 891
Singapore 872
Wilmington 836
Cambridge 832
Nyköping 664
Jacksonville 655
Dearborn 588
London 509
Modena 388
Beijing 261
New York 250
Hefei 246
San Diego 246
Helsinki 202
Princeton 177
Sofia 162
Jakarta 158
Bologna 149
Milan 136
Eugene 135
Izmir 133
Moscow 129
Fremont 123
Munich 109
Shanghai 108
Bremen 102
Council Bluffs 82
Seoul 76
Chicago 68
Redwood City 66
Boardman 65
Los Angeles 62
Des Moines 59
Brussels 54
Dublin 48
Reggio Emilia 48
Nuremberg 43
Dallas 42
San Jose 40
Rome 39
Dong Ket 38
Toronto 37
Turku 36
Parma 35
Ottawa 33
Brno 28
Kilburn 28
Vienna 27
Guangzhou 26
Las Vegas 26
The Dalles 26
São Paulo 25
Falls Church 24
Kunming 23
Phoenix 23
Belize City 22
Columbus 22
San Francisco 22
Philadelphia 21
Washington 21
Norwalk 20
Albuquerque 19
Verona 19
Lauterbourg 18
Rimini 18
Amsterdam 17
Brooklyn 17
Chiswick 17
Frankfurt am Main 17
Lappeenranta 17
Paris 17
Portsmouth 17
Palermo 16
Salt Lake City 16
Wuhan 16
Düsseldorf 15
Atlanta 14
Hounslow 14
Leawood 14
Nanjing 14
Perugia 14
Saint Louis 14
San Mateo 14
Stockholm 14
Belo Horizonte 12
Buffalo 12
Caltanissetta 12
Hanoi 12
Turin 12
Jinan 11
Padova 11
Totale 25.718
Salva come PNG Salva come JPEG
Nome #
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 350
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 314
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 305
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 302
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 294
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 285
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 283
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 282
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 275
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 273
HHV-6A in syncytial giant-cell hepatitis 272
Translational challenges of human herpesvirus 6 chromosomal integration. 271
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 264
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 262
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 259
B cells and herpesviruses: a model of lymphoproliferation 257
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 257
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 254
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 254
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 249
Acute appendicitis in adult neutropenic patients with hematologic malignancies 248
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 248
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 247
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 247
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 245
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 243
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 242
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 242
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 242
Mucorales-specific T cells in patients with hematologic malignancies 241
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 241
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 238
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 238
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 237
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 234
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 233
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 232
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 232
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 230
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 229
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 227
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 227
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 225
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 224
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 223
Parvoviruses in blood donors and transplant patients, Italy 222
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 221
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 220
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 219
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 218
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 218
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 218
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 217
Diagnosis of aspergillosis: Role of proteomics 217
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 216
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 215
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 214
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 214
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 214
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 213
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 213
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 212
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 212
Breast Location for De Novo Extramedullary Myeloid Sarcoma 212
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 210
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 210
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 209
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 203
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 203
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 202
Kaposi's sarcoma after liver transplantation 202
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 202
How I treat HHV8/KSHV-related diseases in posttransplant patients. 201
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 201
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 201
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 200
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 199
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 198
Pain and emotional distress in leukemia patients at diagnosis. 197
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 197
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 197
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 197
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 196
Long-term cognitive sequelae in a case of Wernicke’s encephalopathy after allogeneic stem cell transplantation 195
Immunity to polyomavirus BK infection: Immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity 195
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 189
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 189
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response 188
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 187
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 187
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 187
'Gloves and socks' papular purpuric syndrome following primary infection with parvovirus B19: a link between dermatologists and haematologists 184
Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment 184
Philadelphia chromosome-positive acute lymphoblastic leukemia 183
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 183
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 183
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 183
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 182
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. 182
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 181
Totale 22.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 0 0 0 0 0 0 0 0 228
2020/20214.535 316 228 346 500 493 435 304 513 218 556 338 288
2021/20223.733 247 433 370 185 85 173 203 181 349 315 622 570
2022/20234.019 510 454 278 366 545 502 105 429 429 74 167 160
2023/20242.910 102 141 189 267 527 275 313 437 59 90 185 325
2024/20258.680 294 120 157 574 1.524 1.252 628 483 1.254 482 908 1.004
Totale 34.114